Royal Bank of Canada’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Royal Bank of Canada’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,625	Closed	-$120K	–	7452
2024 Q3	$120K	Buy	3,625 +214	+6%	+$7.37K	﹤0.01%	5216
2024 Q2	$92K	Buy	3,411 +2,842	+499%	+$56K	﹤0.01%	5317
2024 Q1	$12K	Sell	569 -4,603	-89%	-$100K	﹤0.01%	6149
2023 Q4	$31K	Buy	5,172 +2,502	+94%	+$12.5K	﹤0.01%	6178
2023 Q3	$15K	Buy	2,670 +919	+52%	+$5.92K	﹤0.01%	6297
2023 Q2	$13K	Buy	+1,751	New	+$13.3K	﹤0.01%	6396
2022 Q4	–	Sell	-15	Closed	–	–	8229
2022 Q3	$0	Buy	+15	New	+$55	﹤0.01%	8287

Royal Bank of Canada's LBPH Position: Q4 2024 in Review

Royal Bank of Canada sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 3,625 shares — an estimated $120K sold.

Royal Bank of Canada first reported a position in LBPH in Q3 2022 and held it in 7 quarters. The position peaked at $120K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Royal Bank of Canada reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Royal Bank of Canada sold 3,625 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $120K.
Royal Bank of Canada first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Royal Bank of Canada's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $120K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.